The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
by The Investment U Research Team
While breaking 1,000 may be a powerful psychological support level for the S&P 500, many technical traders will be watching to see if the market can move past 1,005. For technicians, this is a strong support and resistance level that, once breached, could see the market move quickly up another 90 points.
Bespoke gave us some clues to just how big some of the recent winners have been – their list of the top forty stocks shows the worst performer had a 400% gain.
Not bad for a recovery.
There’s still a lot of money on the sidelines, but many who have sat out the past four months are beginning to realize they may have missed the boat. From it’s low on March 9, the S&P 500 has climbed almost 50%. However, if it would climb up close to last year’s summer levels it would mean we have another 20% move ahead of us.
The news is starting to turn more positive, and even consumer spending is starting to (slightly) loosen up.
What does it means for markets? Well for starters, it means that volatility will still be relatively high. Profit taking will mute many big up days, like yesterday, as traders seek to lock in those gains.
But it will also mean that we as getting close to a normal market where stock picking and making correct investment choices will become important again. In March, you could have thrown a dart at the markets and found a stock that would move up by 50% or more.
Now we’re going to be moving back to a more competitive environment where earnings and performance matter.
- Thrills of Victory, and Agony of Repeat
- Risk Returns – And So Does Fear
- Four Commodities… Four Ways to Profit
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed